Novelix Pharmaceuticals Ltd — Important, 16-07-2026: Company Update

Novelix Pharmaceuticals has provided a certificate from its Registrar and Share Transfer Agent for the quarter. This certificate confirms that no securities were received for dematerialization or rematerialization during the period. This is a routine compliance filing, important for maintaining transparency in how shareholder records and electronic share transfers are managed. It indicates a period of no conversion activity between physical and electronic share formats, reassuring investors about the stable handling of their shareholdings.